X4 Pharmaceuticals Inc (XFOR) currently has a stock price of $3.92. The stock saw a sharp increase in the last trading session, hitting a high of $75.0 after opening at $3.92. The lowest recorded price for the day was $3.5 before it closed at $3.18.
X4 Pharmaceuticals Inc’s stock has had a tumultuous market performance. The 1-year high for the company’s stock was $26.83 on 12/31/24, and the lowest price during the same period was recorded at $1.35 on 08/11/25.
52-week price history of XFOR Stock
Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. X4 Pharmaceuticals Inc’s current trading price is -85.39% away from its 52-week high, while its distance from the 52-week low is 190.37%. The stock’s price range for this period has remained between $1.35 and $26.83. The Healthcare sector company’s shares managed to surpass a trading volume of around 3.25 million for the day, which was noticeably lower compared to the shares’ average daily volume of 3.98 million over the last three months.
Financial Performance and Market Capitalization
X4 Pharmaceuticals Inc (XFOR) has experienced a quarterly rise of 21.36% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 88.00M and boasts a workforce of 143 employees.
Analysts’ Ratings For X4 Pharmaceuticals Inc
As of right now, 3 analysts are rating X4 Pharmaceuticals Inc as a BUY, 1 of the polled analysts branded the stock as an OVERWEIGHT, 0 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 3.28, with a change in price of -3.17. Similarly, X4 Pharmaceuticals Inc recorded 2,591,427 in trading volume during the last 100 days, posting a change of -44.73%.
XFOR Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for XFOR stands at 19.65. Similarly, the long-term debt-to-equity ratio is also 19.31.
XFOR Stock Stochastic Average
As of today, the raw stochastic average of X4 Pharmaceuticals Inc over the last 50 days is at 99.64%. This shows a increasee from the raw stochastic average of the previous 20 days, which was recorded at 99.64%. Further, the company’s Stochastic %K and %D values for the last 20 days were 85.28% and 76.20%, respectively.
XFOR Stock Price Performance Analysis
A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. Year to date metric has recorded a loss of -82.30%.However, over the last six months, we can see a stronger performance of -72.03%. Over the last 30 days, the price of XFOR has fallen by 114.21%. And in the last five days, it has surged by 37.54%.
